The SamuxMP enables routine quantification of empty/full AAV capsid ratios
The SamuxMP
Designed to be easy to use with only basic training, the SamuxMP
mass photometer is utilized in adeno-associated virus (AAV)
analytics. The instrument has a mass range tailored for AAV analysis and
provides accurate results in less than five minutes from sample loading to final result. Combined with low-operational costs and a small footprint, the SamuxMP enables routine quantification of empty/full AAV capsid ratios, even in smaller labs, to set a new standard in AAV characterization.
The SamuxMP is designed to overcome the drawbacks of the current analytical methods by enabling users to rapidly and cost- effectively determine empty/full capsid ratios for AAVs of any serotype at the bench using low sample volumes and concentrations with minimal sample preparation. This is intended to enhance productivity and speed up workflows through more frequent analyses in-house, making R&D and process development of gene therapies and AAV-based therapeutics significantly more efficient.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.